• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
Labcorp, Quest, and ARUP Develop Bird Flu Tests with CDC Help

Labcorp, Quest, and ARUP Develop Bird Flu Tests with CDC Help

by Ron Shinkman | Jan 28, 2025 | Clinical Diagnostics Insider, Testing Trends-dtet

The assays were developed with the CDC as part of recent trend of public-private partnerships to improve pandemic preparedness

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Diagnostics Pipeline: Testing for Intestinal Parasites Takes Step Forward

Diagnostics Pipeline: Testing for Intestinal Parasites Takes Step Forward

by Ron Shinkman | Nov 25, 2024 | Clinical Diagnostics Insider, FDA-dtet

The EasyScreen assay received 510(k) clearance from the Food and Drug Administration earlier this year–but with a catch

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
The Benefits of Group A Streptococcus NAAT

The Benefits of Group A Streptococcus NAAT

by Tyler Radke, MLS(ASCP)CM | Apr 25, 2024 | Essential, Lab Industry Advisor, Operations-lca

Labs that invested heavily in POC molecular tests during COVID-19 are well positioned to leverage this equipment toward GAS diagnostics

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Pandemics: Prediction, Prevention, and Response

Pandemics: Prediction, Prevention, and Response

by Michael Schubert, PhD | Mar 22, 2024 | Clinical Diagnostics Insider, Emerging Tests-dtet, Testing Trends-dtet

Recent efforts to forecast the next infectious disease outbreak and steps labs can take to ensure they’re prepared.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Expert Q&A: Lessons Learned from a Total Laboratory Automation Project

Expert Q&A: Lessons Learned from a Total Laboratory Automation Project

by Rachel Muenz | Mar 22, 2024 | Clinical Diagnostics Insider, Special Focus-dtet

Clinical Microbiology division head Jeff Fuller, FCCM, discusses his clinical laboratory’s recent automation transformation and offers tips to ensure success

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries

Sign up for our free weekly Lab & Pathology Insider email newsletter

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com